Cargando…
Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study
To validate the revised 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer on the survival of patients who underwent radical hysterectomy for 2009 FIGO stage IB carcinomas. We retrospectively identified and reviewed 251 patients treated with radical...
Autores principales: | Zeng, Jing, Qu, Pengpeng, Hu, Yuanjing, Sun, Peisong, Qi, Ji, Zhao, Guiling, Gao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440235/ https://www.ncbi.nlm.nih.gov/pubmed/32311956 http://dx.doi.org/10.1097/MD.0000000000019714 |
Ejemplares similares
-
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial
por: Hu, Yingjie, et al.
Publicado: (2022) -
Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems
por: Shin, Wonkyo, et al.
Publicado: (2021) -
Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014) -
Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
por: Lee, Jeongshim, et al.
Publicado: (2016) -
Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes
por: Yang, Eun Jung, et al.
Publicado: (2022)